BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mattonen SA, Palma DA, Haasbeek CJ, Senan S, Ward AD. Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a quantitative analysis of CT density changes. Acta Oncol 2013;52:910-8. [PMID: 23106174 DOI: 10.3109/0284186X.2012.731525] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Ahmed N, Kidane B, Wang L, Nugent Z, Moldovan N, McElrea A, Shariati-Ievari S, Qing G, Tan L, Buduhan G, Srinathan SK, Meyers R, Aliani M. Metabolic Alterations in Sputum and Exhaled Breath Condensate of Early Stage Non-Small Cell Lung Cancer Patients After Surgical Resection: A Pilot Study. Front Oncol 2022;12:874964. [PMID: 35719971 DOI: 10.3389/fonc.2022.874964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chandy E, Szmul A, Stavropoulou A, Jacob J, Veiga C, Landau D, Wilson J, Gulliford S, Fenwick JD, Hawkins MA, Hiley C, McClelland JR. Quantitative Analysis of Radiation-Associated Parenchymal Lung Change. Cancers (Basel) 2022;14:946. [PMID: 35205693 DOI: 10.3390/cancers14040946] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Lee K, Le T, Hau E, Hanna GG, Gee H, Vinod S, Dammak S, Palma D, Ong A, Yeghiaian-Alvandi R, Buck J, Lim R. A systematic review into the radiological features predicting local recurrence after stereotactic ablative body radiotherapy (SABR) in patients with non-small cell lung cancer (NSCLC): Local recurrence features of NSCLC post-SABR. Int J Radiat Oncol Biol Phys 2021:S0360-3016(21)03235-1. [PMID: 34879247 DOI: 10.1016/j.ijrobp.2021.11.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Caruso D, Pucciarelli F, Zerunian M, Ganeshan B, De Santis D, Polici M, Rucci C, Polidori T, Guido G, Bracci B, Benvenga A, Barbato L, Laghi A. Chest CT texture-based radiomics analysis in differentiating COVID-19 from other interstitial pneumonia. Radiol Med 2021. [PMID: 34347270 DOI: 10.1007/s11547-021-01402-3] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
5 Capobianco E, Deng J. Radiomics at a Glance: A Few Lessons Learned from Learning Approaches. Cancers (Basel) 2020;12:E2453. [PMID: 32872466 DOI: 10.3390/cancers12092453] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
6 Zhu H, Xu Y, Liang N, Sun H, Huang Z, Xie S, Wang W. Assessment of Clinical Stage IA Lung Adenocarcinoma with pN1/N2 Metastasis Using CT Quantitative Texture Analysis. Cancer Manag Res 2020;12:6421-30. [PMID: 32801882 DOI: 10.2147/CMAR.S251598] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
7 Frerker B, Hildebrandt G. Distinguishing Radiation Pneumonitis from Local Tumour Recurrence Following SBRT for Lung Cancer

]]>. RMI 2020;Volume 13:1-23. [DOI: 10.2147/rmi.s176901] [Reference Citation Analysis]
8 Al Feghali KA, Wu QC, Devpura S, Liu C, Ghanem AI, Wen NW, Ajlouni M, Simoff MJ, Movsas B, Chetty IJ. Correlation of normal lung density changes with dose after stereotactic body radiotherapy (SBRT) for early stage lung cancer. Clin Transl Radiat Oncol 2020;22:1-8. [PMID: 32140574 DOI: 10.1016/j.ctro.2020.02.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Shi L, He Y, Yuan Z, Benedict S, Valicenti R, Qiu J, Rong Y. Radiomics for Response and Outcome Assessment for Non-Small Cell Lung Cancer. Technol Cancer Res Treat 2018;17:1533033818782788. [PMID: 29940810 DOI: 10.1177/1533033818782788] [Cited by in Crossref: 30] [Cited by in F6Publishing: 42] [Article Influence: 7.5] [Reference Citation Analysis]
10 Dennie C, Thornhill R, Souza CA, Odonkor C, Pantarotto JR, MacRae R, Cook G. Quantitative texture analysis on pre-treatment computed tomography predicts local recurrence in stage I non-small cell lung cancer following stereotactic radiation therapy. Quant Imaging Med Surg 2017;7:614-22. [PMID: 29312866 DOI: 10.21037/qims.2017.11.01] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
11 Wen Q, Zhu J, Meng X, Ma C, Bai T, Sun X, Yu J. The Value of CBCT-based Tumor Density and Volume Variations in Prediction of Early Response to Chemoradiation Therapy in Advanced NSCLC. Sci Rep 2017;7:14650. [PMID: 29116100 DOI: 10.1038/s41598-017-14548-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
12 Jiao Y, Ren Y, Zheng X. [Quantitative Imaging Assessment of Tumor Response to Chemoradiation 
in Lung Cancer]. Zhongguo Fei Ai Za Zhi 2017;20:407-14. [PMID: 28641699 DOI: 10.3779/j.issn.1009-3419.2017.06.07] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Mattonen SA, Ward AD, Palma DA. Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply? Br J Radiol 2016;89:20160113. [PMID: 27245137 DOI: 10.1259/bjr.20160113] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
14 Mazzola R, Fiorentino A, Ricchetti F, Giaj Levra N, Fersino S, Di Paola G, Lo Casto A, Ruggieri R, Alongi F. Cone-beam computed tomography in lung stereotactic ablative radiation therapy: predictive parameters of early response. Br J Radiol 2016;89:20160146. [PMID: 27245138 DOI: 10.1259/bjr.20160146] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
15 Knoll MA, Salvatore M, Sheu RD, Knoll AD, Kerns SL, Lo YC, Rosenzweig KE. The use of isodose levels to interpret radiation induced lung injury: a quantitative analysis of computed tomography changes. Quant Imaging Med Surg 2016;6:35-41. [PMID: 26981453 DOI: 10.3978/j.issn.2223-4292.2016.02.07] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
16 Cascales A, Martinetti F, Belemsagha D, Le Pechoux C. Challenges in the treatment of early non-small cell lung cancer: what is the standard, what are the challenges and what is the future for radiotherapy? Transl Lung Cancer Res 2014;3:195-204. [PMID: 25806301 DOI: 10.3978/j.issn.2218-6751.2014.08.03] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
17 Arcangeli S, Agolli L, Portalone L, Migliorino MR, Lopergolo MG, Monaco A, Dognini J, Pressello MC, Bracci S, Donato V. Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLC. Br J Radiol 2015;88:20140728. [PMID: 25645106 DOI: 10.1259/bjr.20140728] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
18 Alic L, Niessen WJ, Veenland JF. Quantification of heterogeneity as a biomarker in tumor imaging: a systematic review. PLoS One 2014;9:e110300. [PMID: 25330171 DOI: 10.1371/journal.pone.0110300] [Cited by in Crossref: 93] [Cited by in F6Publishing: 93] [Article Influence: 11.6] [Reference Citation Analysis]
19 Fried DV, Tucker SL, Zhou S, Liao Z, Mawlawi O, Ibbott G, Court LE. Prognostic value and reproducibility of pretreatment CT texture features in stage III non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2014;90:834-42. [PMID: 25220716 DOI: 10.1016/j.ijrobp.2014.07.020] [Cited by in Crossref: 114] [Cited by in F6Publishing: 116] [Article Influence: 14.3] [Reference Citation Analysis]
20 Alobaidli S, McQuaid S, South C, Prakash V, Evans P, Nisbet A. The role of texture analysis in imaging as an outcome predictor and potential tool in radiotherapy treatment planning. Br J Radiol 2014;87:20140369. [PMID: 25051978 DOI: 10.1259/bjr.20140369] [Cited by in Crossref: 58] [Cited by in F6Publishing: 67] [Article Influence: 7.3] [Reference Citation Analysis]
21 Mattonen SA, Huang K, Ward AD, Senan S, Palma DA. New techniques for assessing response after hypofractionated radiotherapy for lung cancer. J Thorac Dis 2014;6:375-86. [PMID: 24688782 DOI: 10.3978/j.issn.2072-1439.2013.11.09] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
22 Daly ME, Beckett LA, Chen AM. Does early posttreatment surveillance imaging affect subsequent management following stereotactic body radiation therapy for early-stage non-small cell lung cancer? Pract Radiat Oncol 2014;4:240-6. [PMID: 25012832 DOI: 10.1016/j.prro.2013.08.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
23 De Ruysscher D, Sharifi H, Defraene G, Kerns SL, Christiaens M, De Ruyck K, Peeters S, Vansteenkiste J, Jeraj R, Van Den Heuvel F, van Elmpt W. Quantification of radiation-induced lung damage with CT scans: the possible benefit for radiogenomics. Acta Oncol 2013;52:1405-10. [PMID: 23957564 DOI: 10.3109/0284186X.2013.813074] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 4.3] [Reference Citation Analysis]